文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

干粉吸入器设计和颗粒技术在增强肺部药物沉积中的作用:挑战与未来策略。

Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.

机构信息

Pharmacy Discipline, School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.

Centre for Immunology and Infection Control (CIIC), Queensland University of Technology, Brisbane, QLD, Australia.

出版信息

Daru. 2024 Dec;32(2):761-779. doi: 10.1007/s40199-024-00520-3. Epub 2024 Jun 11.


DOI:10.1007/s40199-024-00520-3
PMID:38861247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11555000/
Abstract

OBJECTIVES: The efficient delivery of drugs from dry powder inhaler (DPI) formulations is associated with the complex interaction between the device design, drug formulations, and patient's inspiratory forces. Several challenges such as limited emitted dose of drugs from the formulation, low and variable deposition of drugs into the deep lungs, are to be resolved for obtaining the efficiency in drug delivery from DPI formulations. The objective of this study is to review the current challenges of inhaled drug delivery technology and find a way to enhance the efficiency of drug delivery from DPIs. METHODS/EVIDENCE ACQUISITION: Using appropriate keywords and phrases as search terms, evidence was collected from the published articles following SciFinder, Web of Science, PubMed and Google Scholar databases. RESULTS: Successful lung drug delivery from DPIs is very challenging due to the complex anatomy of the lungs and requires an integrated strategy for particle technology, formulation design, device design, and patient inhalation force. New DPIs are still being developed with limited performance and future device design employs computer simulation and engineering technology to overcome the ongoing challenges. Many issues of drug formulation challenges and particle technology are concerning factors associated with drug dispersion from the DPIs into deep lungs. CONCLUSION: This review article addressed the appropriate design of DPI devices and drug formulations aligned with the patient's inhalation maneuver for efficient delivery of drugs from DPI formulations.

摘要

目的:干粉吸入器(DPI)制剂的药物有效传递与设备设计、药物制剂和患者吸气力之间的复杂相互作用有关。为了提高 DPI 制剂的药物传递效率,需要解决一些挑战,如制剂中药物的发射剂量有限、药物在肺部深处的沉积率低且变化大。本研究旨在综述吸入药物传递技术的当前挑战,并寻找提高 DPI 制剂药物传递效率的方法。

方法/证据获取:使用适当的关键字和短语作为搜索词,从 SciFinder、Web of Science、PubMed 和 Google Scholar 数据库中发表的文章中收集证据。

结果:由于肺部的复杂解剖结构,DPI 制剂的肺部药物传递非常具有挑战性,需要综合考虑颗粒技术、制剂设计、设备设计和患者吸气力等因素。新型 DPI 仍在开发中,但性能有限,未来的设备设计采用计算机模拟和工程技术来克服当前的挑战。药物制剂挑战和颗粒技术的许多问题是与 DPI 向肺部深处分散药物相关的关注因素。

结论:本文讨论了 DPI 装置和药物制剂的适当设计,以及与患者吸气动作的一致性,以实现 DPI 制剂的药物有效传递。

相似文献

[1]
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.

Daru. 2024-12

[2]
The clinical relevance of dry powder inhaler performance for drug delivery.

Respir Med. 2014-8

[3]
Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.

Comput Biol Med. 2017-5-1

[4]
Dry powder inhalation: past, present and future.

Expert Opin Drug Deliv. 2017-4

[5]
Dry powder inhalers in COPD, lung inflammation and pulmonary infections.

Expert Opin Drug Deliv. 2014-11-12

[6]
Building respirable powder architectures: utilizing polysaccharides for precise control of particle morphology for enhanced pulmonary drug delivery.

Expert Opin Drug Deliv. 2024-6

[7]
Understanding the role of swirling flow in dry powder inhalers: Implications for design considerations and pulmonary delivery.

J Control Release. 2024-9

[8]
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

J Aerosol Med Pulm Drug Deliv. 2020-4

[9]
Formulation techniques for high dose dry powders.

Int J Pharm. 2018-5-17

[10]
Physical stability of dry powder inhaler formulations.

Expert Opin Drug Deliv. 2019-12-13

引用本文的文献

[1]
Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: and barrier-overcoming strategies.

Drug Deliv. 2025-12

[2]
Zanamivir exposure in healthy rats and rats with acute lung injury.

Ann Med. 2025-12

[3]
Optimization, In Vitro, and In Silico Characterization of Theophylline Inhalable Powder Using Raffinose-Amino Acid Combination as Fine Co-Spray-Dried Carriers.

Pharmaceutics. 2025-4-3

[4]
Development and Characterization of Spray-Dried Combined Levofloxacin-Ambroxol Dry Powder Inhaler Formulation.

Pharmaceutics. 2024-11-22

本文引用的文献

[1]
Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.

Int J Pharm. 2024-4-10

[2]
Development of a Novel Bronchodilator Vaping Drug Delivery System Based on Thermal Degradation Properties.

Pharmaceuticals (Basel). 2023-12-15

[3]
A counter-swirl design concept for dry powder inhalers.

Int J Pharm. 2024-1-25

[4]
Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations.

Int J Pharm. 2023-8-25

[5]
Long-Term Cost-Effectiveness of Digital Inhaler Adherence Technologies in Difficult-to-Treat Asthma.

J Allergy Clin Immunol Pract. 2023-10

[6]
The role of capsule aperture size on the dispersion of carrier-based formulation at different air flowrates.

Int J Pharm. 2023-7-25

[7]
Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis.

Pharmaceutics. 2023-5-13

[8]
Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research.

AAPS PharmSciTech. 2023-4-4

[9]
Impact of Leucine and Magnesium Stearate on the Physicochemical Properties and Aerosolization Behavior of Wet Milled Inhalable Ibuprofen Microparticles for Developing Dry Powder Inhaler Formulation.

Pharmaceutics. 2023-2-16

[10]
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies.

J Control Release. 2023-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索